Last mentioned: Mar 18, 2026
Expected Response
Deadline for CDSCO to justify the delay in regulatory action (Estimated).
Contempt Petition Filed
Petitioners allege CDSCO failed to act on the court's previous safety mandate.
Notice Issued
Justice Sachin Datta issues formal contempt notice seeking a response from the CDSCO.
HC Ruling
Delhi High Court sets aside the CAT order, allowing investigations to proceed.
Initial Judicial Order
Delhi HC directs CDSCO to examine the safety of diabetes drugs used for weight management.
CAT Stay
Central Administrative Tribunal stays disciplinary proceedings against Wankhede.
CBI FIR
CBI registers a case against Wankhede for alleged bribery and extortion.
Cordelia Raid
NCB team led by Wankhede raids cruise ship, leading to Aryan Khan's arrest.
The Delhi High Court has initiated contempt proceedings against India's top drug regulator, the CDSCO, for failing to act on a judicial mandate to evaluate the safety of diabetes medications used off-label for weight loss. This escalation highlights growing judicial impatience with regulatory inertia regarding the global surge in GLP-1 receptor agonist use.
The Delhi High Court has vacated a Central Administrative Tribunal (CAT) order that previously stayed disciplinary and legal proceedings against IRS officer Sameer Wankhede. This ruling clears the path for investigative agencies to resume actions related to alleged misconduct during his tenure at the Narcotics Control Bureau.